Bristol-Myers says Starboard nominated five directors, bought shares
February 20, 2019 at 10:05 AM EST
Bristol-Myers Squibb Co. said on Wednesday that activist hedge fund Starboard Value LP wants to add five directors to its board and bought one million shares after the pharmaceutical company said it plans to buy biotech company Celgene Corp.
